Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages 736-741

  Konstantinidis, Lazaros ^a   Ambresin, Aude ^a   Zografos, Leonidas ^a   Mantel, Irmela ^a  

^a Jules Gonin University   (Switzerland)

Author keywords

age related macular degeneration; intravitreal ranibizumab; predominantly classic choroidal neovascularization; retinal pigment epithelial tear

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DRUG ADMINISTRATION SCHEDULE; EYEGLASSES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INCIDENCE; INJECTIONS, INTRAOCULAR; MACULAR DEGENERATION; MALE; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 78349235444     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01547.x     Document Type: Article

References (43)

1. Apte RS, (2007): Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD. Int Ophthalmol 27: 59 - 61.
2. Arias L, Caminal JM, Rubio M, Pujol O, &, Arruga J, (2007): Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol 17: 992 - 995.
3. Bakri SJ, &, Kitzmann AS, (2007): Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 143: 505 - 507.
4. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, &, Schneider S, (2006): Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432 - 1444.
5. Cantrill HL, Ramsay RC, &, Knobloch WH, (1983): Rips in the pigment epithelium. Arch Ophthalmol 101: 1074 - 1079.
6. Carvounis PE, Kopel AC, &, Benz MS, (2007): Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 143: 504 - 505.
7. Casswell AG, Kohen D, &, Bird AC, (1985): Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69: 397 - 403.
8. Chan CK, Meyer CH, Gross JG, et al. (2007): Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 27: 541 - 551.
9. Chang LK, Flaxel CJ, Lauer AK, &, Sarraf D, (2007): RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 27: 857 - 863.
10. Chiang A, Chang LK, Yu F, &, Sarraf D, (2008): Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 28: 1265 - 1269.
11. Chuang EL, &, Bird AC, (1988): Repair after tears of the retinal pigment epithelium. Eye 2: 106 - 113.
12. Coscas G, Koenig F, &, Soubrane G, (1990): The pretear characteristics of pigment epithelial detachments. A study of 40 eyes. Arch Ophthalmol 108: 1687 - 1693.
13. Decker WL, Sanborn GE, Ridley M, Annesley WH Jr, &, Sorr EM, (1983): Retinal pigment epithelial tears. Ophthalmology 90: 507 - 512.
14. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, &, Apte RS, (2006): Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 141: 752 - 754.
15. Fasolino G, Bamonte G, Patelli F, Centola M, &, Petroni S, (2007): Retinal pigment epithelial tear after intravitreal injection of triamcinolone acetonide for neovascular pigment epithelial detachment: a mechanical explanation. Acta Ophthalmol Scand 85: 575 - 576.
16. Fung AE, Lalwani GA, Rosenfeld PJ, et al. (2007): An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143: 566 - 583.
17. Gamulescu MA, Framme C, &, Sachs H, (2007): RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol 245: 1037 - 1040.
18. Gass JD, (1984): Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 98: 700 - 706.
19. Gelisken F, Inhoffen W, Partsch M, Schneider U, &, Kreissig I, (2001): Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 131: 518 - 520.
20. Gelisken F, Ziemssen F, Voelker M, &, Bartz-Schmidt KU, (2006): Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 84: 833 - 834.
21. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, &, Inhoffen W, (2009): Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye 23: 694 - 702.
22. Goldstein M, Heilweil G, Barak A, &, Loewenstein A, (2005): Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 19: 1315 - 1324.
23. Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, &, D'Amore PA, (2003): Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res 77: 593 - 599.
24. Hoskin A, Bird AC, &, Sehmi K, (1981): Tears of detached retinal pigment epithelium. Br J Ophthalmol 65: 417 - 422.
25. Kiss C, Michels S, Prager F, Geitzenauer W, &, Schmidt-Erfurth U, (2007): Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol Scand 85: 902 - 903.
26. Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, &, Ulbig MW, (2008): Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe 105: 158 - 164.
27. Lee GK, Lai TY, Chan WM, &, Lam DS, (2007): Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 1225 - 1227.
28. Macular Photocoagulation Study Group (1991): Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 109: 1242 - 1257.
29. Meyer CH, &, Toth CA, (2001): Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 239: 325 - 333.
30. Meyer CH, Mennel S, Schmidt JC, &, Kroll P, (2006): Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 90: 1207 - 1208.
31. Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, &, Schmidt-Erfurth U, (2006): Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 141: 396 - 398.
32. Moore DJ, Hussain AA, &, Marshall J, (1995): Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 36: 1290 - 1297.
33. Moorfields Macular Study Group (1982): Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation. Br J Ophthalmol 66: 1 - 16.
34. Pauleikhoff D, Harper CA, Marshall J, &, Bird AC, (1990): Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 97: 171 - 178.
35. Pauleikhoff D, Loffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, &, Bird AC, (2002): Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240: 533 - 538.
36. Pece A, Introini U, Bottoni F, &, Brancato R, (2001): Acute retinal pigment epithelial tear after photodynamic therapy. Retina 21: 661 - 665.
37. Pece A, Isola V, Vadala M, &, Calori G, (2007): Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Retina 27: 342 - 348.
38. Poliner LS, Olk RJ, Burgess D, &, Gordon ME, (1986): Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 93: 543 - 551.
39. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, &, Kim RY, (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419 - 1431.
40. Shah CP, Hsu J, Garg SJ, Fischer DH, &, Kaiser R, (2006): Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142: 1070 - 1072.
41. Verteporfin Roundtable Participants (2005): Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 25: 119 - 134.
42. Weinberger AW, Thiel M, Mohammadi B, Theofylaktopoulos I, Thumann G, &, Walter P, (2007): Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Am J Ophthalmol 144: 294 - 296.
43. Yeo JH, Marcus S, &, Murphy RP, (1988): Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 95: 8 - 13.